ANI Pharmaceuticals Stock Forecast

Stock Price Forecast

The 8 analysts with 12-month price forecasts for ANI Pharmaceuticals stock have an average target of 79.75, with a low estimate of 62 and a high estimate of 94. The average target predicts an increase of 18.25% from the current stock price of 67.44.

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$62	$79.75	$83	$94
Change	-8.07%	+18.25%	+23.07%	+39.38%

Analyst Ratings

The average analyst rating for ANI Pharmaceuticals stock from 8 stock analysts is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Oct '24	Nov '24	Dec '24	Jan '25	Feb '25	Mar '25
Strong Buy	2	2	2	2	2	3
Buy	3	3	4	4	4	4
Hold	1	1	1	1	1	1
Sell	0	0	0	0	0	0
Strong Sell	0	0	0	0	0	0
Total	6	6	7	7	7	8

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $94	Strong Buy	Reiterates	$94	+39.38%	Mar 17, 2025
Glen Santangelo Jefferies	Jefferies	Strong Buy Initiates $80	Strong Buy	Initiates	$80	+18.62%	Mar 14, 2025
Ekaterina Knyazkova JP Morgan	JP Morgan	Buy Initiates $85	Buy	Initiates	$85	+26.04%	Mar 12, 2025
Vamil Divan Guggenheim	Guggenheim	Strong Buy Maintains $84 → $86	Strong Buy	Maintains	$84 → $86	+27.52%	Mar 5, 2025
Oren Livnat HC Wainwright & Co.	HC Wainwright & Co.	Strong Buy Reiterates $94	Strong Buy	Reiterates	$94	+39.38%	Mar 3, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

784.08M

from 614.38M

27.62%

from 614.38M

Revenue Next Year

844.53M

from 784.08M

7.71%

from 784.08M

EPS This Year

6.45

from -1.04

EPS Next Year

7.12

from 6.45

10.45%

from 6.45

Fiscal Year	FY 2020	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025	FY 2026	FY 2027
Period Ending	Dec 31, 2020	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024	Dec 31, 2025	Dec 31, 2026	Dec 31, 2027
Revenue	208.48M	216.14M	316.39M	486.82M	614.38M	784.08M	844.53M	899.61M
Revenue Growth	0.93%	3.68%	46.38%	53.87%	26.20%	27.62%	7.71%	6.52%
EPS	-1.88	-3.40	-3.05	0.85	-1.04	6.45	7.12	8.24
EPS Growth	-	-	-	-	-	-	10.45%	15.71%
Forward PE	-	-	-	-	-	10.46	9.47	8.19
No. Analysts	-	-	-	-	-	10	10	8

Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue	2025	2026	2027
High	811.9M	910.9M	995.5M
Avg	784.1M	844.5M	899.6M
Low	747.0M	778.6M	803.0M

Revenue Growth

Revenue Growth	2025	2026	2027
High	32.1%	16.2%	17.9%
Avg	27.6%	7.7%	6.5%
Low	21.6%	-0.7%	-4.9%

EPS Forecast

EPS	2025	2026	2027
High	6.79	8.48	10.43
Avg	6.45	7.12	8.24
Low	6.07	6.30	6.64

EPS Growth

EPS Growth	2025	2026	2027
High	-	31.6%	46.5%
Avg	-	10.4%	15.7%
Low	-	-2.2%	-6.7%

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.